The long tail of a demon drug: The ‘bath salts’ risk environment
Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use b...
Gespeichert in:
Veröffentlicht in: | The International journal of drug policy 2018-01, Vol.51, p.111-116 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 116 |
---|---|
container_issue | |
container_start_page | 111 |
container_title | The International journal of drug policy |
container_volume | 51 |
creator | Elliott, Luther Benoit, Ellen Campos, Stephanie Dunlap, Eloise |
description | Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the ‘long tail’ of myriad lesser-known products and the diminished centrality of ‘superstars’ and ‘hits’. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug ‘analogues’ legislation and greater involvement with NPS education and testing by harm reduction agencies. |
doi_str_mv | 10.1016/j.drugpo.2017.10.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5762257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0955395917303274</els_id><sourcerecordid>2019056499</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-ac087609a342c2a22f8cfc466d1e56e6f0f838be53b5fa8af4c3449ebc8cd8173</originalsourceid><addsrcrecordid>eNp9kMtqGzEUhkVoSJzLG5Qi6HpcSSONpC4KJW3SQCAbZy00miNb7njkSmNDdnmM9vXyJJnBzqWbrA6cc_4LH0IfKZlSQqsvy2mTNvN1nDJC5bCaEiIP0IQqWRZcCvUBTYgWoii10MfoJOclIYRTTo_QMdOMKyXZBP2YLQC3sZvj3oYWR48tbmAVOzy6f8Xj-fHhb237Bc627fPjwz-cQv6NoduGFLsVdP0ZOvS2zXC-n6fo7vLn7OJXcXN7dX3x_aZwgvK-sI4oWRFtS84cs4x55bzjVdVQEBVUnnhVqhpEWQtvlfXclZxrqJ1yjaKyPEXfdr7rTb2Cxg3RybZmncLKpnsTbTD_X7qwMPO4NUJWjInR4PPeIMU_G8i9WcZN6obOZqCoiai41sMX3325FHNO4F8SKDEje7M0O_ajSo7bgf0g-_S23YvoGfZrfRgYbQMkk12AzkETErjeNDG8n_AE-AGZuw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2019056499</pqid></control><display><type>article</type><title>The long tail of a demon drug: The ‘bath salts’ risk environment</title><source>MEDLINE</source><source>PAIS Index</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Access via ScienceDirect (Elsevier)</source><creator>Elliott, Luther ; Benoit, Ellen ; Campos, Stephanie ; Dunlap, Eloise</creator><creatorcontrib>Elliott, Luther ; Benoit, Ellen ; Campos, Stephanie ; Dunlap, Eloise</creatorcontrib><description>Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the ‘long tail’ of myriad lesser-known products and the diminished centrality of ‘superstars’ and ‘hits’. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug ‘analogues’ legislation and greater involvement with NPS education and testing by harm reduction agencies.</description><identifier>ISSN: 0955-3959</identifier><identifier>EISSN: 1873-4758</identifier><identifier>DOI: 10.1016/j.drugpo.2017.10.007</identifier><identifier>PMID: 29248872</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Alkaloids - pharmacology ; Cities ; Consumption ; Drug and Narcotic Control - economics ; Drug and Narcotic Control - methods ; Drug and Narcotic Control - organization & administration ; Drug markets ; Drug policy ; Drugs ; Entertainment industry ; Harm Reduction ; Health Risk Behaviors ; Humans ; Internet ; Legislation ; Legislation, Drug - organization & administration ; Markets ; Novel psychoactive substances ; Profits ; Psychotropic drugs ; Psychotropic Drugs - pharmacology ; Regulation ; Risk assessment ; Risk environment ; Stimulants ; Street Drugs - pharmacology ; Substance-Related Disorders - prevention & control ; Synthetic cathinones ; United States</subject><ispartof>The International journal of drug policy, 2018-01, Vol.51, p.111-116</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Jan 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-ac087609a342c2a22f8cfc466d1e56e6f0f838be53b5fa8af4c3449ebc8cd8173</citedby><cites>FETCH-LOGICAL-c514t-ac087609a342c2a22f8cfc466d1e56e6f0f838be53b5fa8af4c3449ebc8cd8173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.drugpo.2017.10.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27866,27924,27925,30999,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29248872$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elliott, Luther</creatorcontrib><creatorcontrib>Benoit, Ellen</creatorcontrib><creatorcontrib>Campos, Stephanie</creatorcontrib><creatorcontrib>Dunlap, Eloise</creatorcontrib><title>The long tail of a demon drug: The ‘bath salts’ risk environment</title><title>The International journal of drug policy</title><addtitle>Int J Drug Policy</addtitle><description>Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the ‘long tail’ of myriad lesser-known products and the diminished centrality of ‘superstars’ and ‘hits’. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug ‘analogues’ legislation and greater involvement with NPS education and testing by harm reduction agencies.</description><subject>Alkaloids - pharmacology</subject><subject>Cities</subject><subject>Consumption</subject><subject>Drug and Narcotic Control - economics</subject><subject>Drug and Narcotic Control - methods</subject><subject>Drug and Narcotic Control - organization & administration</subject><subject>Drug markets</subject><subject>Drug policy</subject><subject>Drugs</subject><subject>Entertainment industry</subject><subject>Harm Reduction</subject><subject>Health Risk Behaviors</subject><subject>Humans</subject><subject>Internet</subject><subject>Legislation</subject><subject>Legislation, Drug - organization & administration</subject><subject>Markets</subject><subject>Novel psychoactive substances</subject><subject>Profits</subject><subject>Psychotropic drugs</subject><subject>Psychotropic Drugs - pharmacology</subject><subject>Regulation</subject><subject>Risk assessment</subject><subject>Risk environment</subject><subject>Stimulants</subject><subject>Street Drugs - pharmacology</subject><subject>Substance-Related Disorders - prevention & control</subject><subject>Synthetic cathinones</subject><subject>United States</subject><issn>0955-3959</issn><issn>1873-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>7TQ</sourceid><recordid>eNp9kMtqGzEUhkVoSJzLG5Qi6HpcSSONpC4KJW3SQCAbZy00miNb7njkSmNDdnmM9vXyJJnBzqWbrA6cc_4LH0IfKZlSQqsvy2mTNvN1nDJC5bCaEiIP0IQqWRZcCvUBTYgWoii10MfoJOclIYRTTo_QMdOMKyXZBP2YLQC3sZvj3oYWR48tbmAVOzy6f8Xj-fHhb237Bc627fPjwz-cQv6NoduGFLsVdP0ZOvS2zXC-n6fo7vLn7OJXcXN7dX3x_aZwgvK-sI4oWRFtS84cs4x55bzjVdVQEBVUnnhVqhpEWQtvlfXclZxrqJ1yjaKyPEXfdr7rTb2Cxg3RybZmncLKpnsTbTD_X7qwMPO4NUJWjInR4PPeIMU_G8i9WcZN6obOZqCoiai41sMX3325FHNO4F8SKDEje7M0O_ajSo7bgf0g-_S23YvoGfZrfRgYbQMkk12AzkETErjeNDG8n_AE-AGZuw</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Elliott, Luther</creator><creator>Benoit, Ellen</creator><creator>Campos, Stephanie</creator><creator>Dunlap, Eloise</creator><general>Elsevier B.V</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7TQ</scope><scope>8BJ</scope><scope>DHY</scope><scope>DON</scope><scope>FQK</scope><scope>JBE</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>The long tail of a demon drug: The ‘bath salts’ risk environment</title><author>Elliott, Luther ; Benoit, Ellen ; Campos, Stephanie ; Dunlap, Eloise</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-ac087609a342c2a22f8cfc466d1e56e6f0f838be53b5fa8af4c3449ebc8cd8173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Alkaloids - pharmacology</topic><topic>Cities</topic><topic>Consumption</topic><topic>Drug and Narcotic Control - economics</topic><topic>Drug and Narcotic Control - methods</topic><topic>Drug and Narcotic Control - organization & administration</topic><topic>Drug markets</topic><topic>Drug policy</topic><topic>Drugs</topic><topic>Entertainment industry</topic><topic>Harm Reduction</topic><topic>Health Risk Behaviors</topic><topic>Humans</topic><topic>Internet</topic><topic>Legislation</topic><topic>Legislation, Drug - organization & administration</topic><topic>Markets</topic><topic>Novel psychoactive substances</topic><topic>Profits</topic><topic>Psychotropic drugs</topic><topic>Psychotropic Drugs - pharmacology</topic><topic>Regulation</topic><topic>Risk assessment</topic><topic>Risk environment</topic><topic>Stimulants</topic><topic>Street Drugs - pharmacology</topic><topic>Substance-Related Disorders - prevention & control</topic><topic>Synthetic cathinones</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elliott, Luther</creatorcontrib><creatorcontrib>Benoit, Ellen</creatorcontrib><creatorcontrib>Campos, Stephanie</creatorcontrib><creatorcontrib>Dunlap, Eloise</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>PAIS Index</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The International journal of drug policy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elliott, Luther</au><au>Benoit, Ellen</au><au>Campos, Stephanie</au><au>Dunlap, Eloise</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The long tail of a demon drug: The ‘bath salts’ risk environment</atitle><jtitle>The International journal of drug policy</jtitle><addtitle>Int J Drug Policy</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>51</volume><spage>111</spage><epage>116</epage><pages>111-116</pages><issn>0955-3959</issn><eissn>1873-4758</eissn><abstract>Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the ‘long tail’ of myriad lesser-known products and the diminished centrality of ‘superstars’ and ‘hits’. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug ‘analogues’ legislation and greater involvement with NPS education and testing by harm reduction agencies.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>29248872</pmid><doi>10.1016/j.drugpo.2017.10.007</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0955-3959 |
ispartof | The International journal of drug policy, 2018-01, Vol.51, p.111-116 |
issn | 0955-3959 1873-4758 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5762257 |
source | MEDLINE; PAIS Index; Applied Social Sciences Index & Abstracts (ASSIA); Access via ScienceDirect (Elsevier) |
subjects | Alkaloids - pharmacology Cities Consumption Drug and Narcotic Control - economics Drug and Narcotic Control - methods Drug and Narcotic Control - organization & administration Drug markets Drug policy Drugs Entertainment industry Harm Reduction Health Risk Behaviors Humans Internet Legislation Legislation, Drug - organization & administration Markets Novel psychoactive substances Profits Psychotropic drugs Psychotropic Drugs - pharmacology Regulation Risk assessment Risk environment Stimulants Street Drugs - pharmacology Substance-Related Disorders - prevention & control Synthetic cathinones United States |
title | The long tail of a demon drug: The ‘bath salts’ risk environment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T08%3A20%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20long%20tail%20of%20a%20demon%20drug:%20The%20%E2%80%98bath%20salts%E2%80%99%20risk%20environment&rft.jtitle=The%20International%20journal%20of%20drug%20policy&rft.au=Elliott,%20Luther&rft.date=2018-01-01&rft.volume=51&rft.spage=111&rft.epage=116&rft.pages=111-116&rft.issn=0955-3959&rft.eissn=1873-4758&rft_id=info:doi/10.1016/j.drugpo.2017.10.007&rft_dat=%3Cproquest_pubme%3E2019056499%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2019056499&rft_id=info:pmid/29248872&rft_els_id=S0955395917303274&rfr_iscdi=true |